
Encompass Health Rehabilitation Hospital of Irmo now open in South Carolina
BIRMINGHAM, Ala. and IRMO, S.C.
Loading news...

BIRMINGHAM, Ala. and IRMO, S.C.

Eli Lilly and Company's shares rose during the quarter as Zepbound's obesity launch continued to gain strong traction. Cidara Therapeutics' shares rose further following Merck's acquisition of the company in a $9.2 billion all-cash deal announced in November 2025, representing a premium of more than 100% over the prior closing price. Doximity's stock detracted from performance as the company issued disappointing guidance for the next two quarters.

BIRMINGHAM, Ala., Feb. 26, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the Barclays Global Healthcare Conference, which is being held March 10-12, 2026.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

BIRMINGHAM, Ala., Feb. 24, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC), the nation's largest owner and operator of inpatient rehabilitation hospitals, today announced it has been named to the Fortune 2026 World's Most Admired Companies list and the Forbes 2026 America's Best Companies list.

New York, New York--(Newsfile Corp. - February 24, 2026) - NANO Nuclear Energy Inc. (NASDAQ: NNE) ("NANO Nuclear" or "the Company"), a leading advanced nuclear micro modular reactor (MMR) and technology company focused on developing clean energy solutions, today announced that it has signed a Memorandum of Understanding (MOU) with EHC Investment L.L.C (EHC), a diversified United Arab Emirates (UAE) investment holding company based in Abu Dhabi, to explore a joint venture aimed at deploying micro modular reactors, notably NANO Nuclear's KRONOS MMR™ Energy System, and necessary supply chains in the UAE. Figure 1 - NANO Nuclear Energy Inc. Signs a Memorandum of Understanding (MOU) with EHC Investment L.L.C (EHC) to Support the Advancement of the KRONOS MMR™ Energy System in the UAE and Select Markets within the Gulf region.

BIRMINGHAM, Ala., Feb. 19, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.19 per share, payable on April 15, 2026, to holders of record on April 1, 2026.

BIRMINGHAM, Ala. and FLOWOOD, Miss.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) announced today that, along with Encompass Health Corporation (NYSE: EHC), they have collected $43.1 million in full satisfaction of their claims for attorneys' fees and mitigation damages in the Delaware Court of Chancery against former officer Chris Walker, Vistria Group senior partner David Schuppan, and Nautic Partners managing director Christopher Corey. These claims related to the December 2024 judgment in favor of Enhabit and Encompass.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Envestnet Asset Management Inc. reduced its position in shares of Encompass Health Corporation (NYSE: EHC) by 6.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 350,785 shares of the company's stock after selling 25,171 shares during

Encompass Health stands as the leading U.S. inpatient rehabilitation provider, demonstrating superior clinical quality, capital efficiency, and sustainable double-digit EBITDA growth. EHC benefits from demographic tailwinds, regulatory barriers, and a persistent supply-demand imbalance, enabling pricing power and strategic market expansion. Ownership of 79% of its real estate, efficient de novo hospital development, and granular labor management underpin EHC's operational leverage and financial resilience.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

EHC tops Q4 EPS and revenue estimates as revenue per discharge rises, lifting profits, though higher salaries and benefits weigh on results.

Alps Advisors Inc. lessened its stake in shares of Encompass Health Corporation (NYSE: EHC) by 18.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 163,350 shares of the company's stock after selling 35,765 shares during the quarter.

Encompass Health (NYSE: EHC) reported what executives described as a "very strong" fourth quarter, capping a "stellar" 2025 marked by double-digit revenue growth, expanding EBITDA, and continued reductions in premium labor spending even as the company added capacity and treated more patients. Full-year 2025 results highlighted revenue and EBITDA growth Chief Executive Officer Mark Tarr said

Encompass Health Corporation (EHC) Q4 2025 Earnings Call Transcript

The headline numbers for Encompass Health (EHC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Encompass Health (EHC) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $1.29 per share. This compares to earnings of $1.17 per share a year ago.